Q3ZBN4
Gene name |
CUEDC2 |
Protein name |
CUE domain-containing protein 2 |
Names |
|
Species |
Bos taurus (Bovine) |
KEGG Pathway |
bta:516091 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q3ZBN4
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q3ZBN4-F1 | Predicted | AlphaFoldDB |
14 variants for Q3ZBN4
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs440896650 | 22 | A>D | No | EVA | |
| rs436385407 | 27 | L>F | No | EVA | |
| rs474258559 | 28 | D>G | No | EVA | |
| rs386064197 | 175 | A>V | No | EVA | |
| rs876394065 | 195 | D>A | No | EVA | |
| rs876623684 | 210 | S>P | No | EVA | |
| rs434100424 | 220 | D>G | No | EVA | |
| rs465929086 | 224 | D>G | No | EVA | |
| rs445884093 | 227 | I>F | No | EVA | |
| rs432225620 | 228 | H>D | No | EVA | |
| rs470106284 | 235 | E>K | No | EVA | |
| rs452284179 | 237 | P>H | No | EVA | |
| rs432144637 | 238 | K>Q | No | EVA | |
| rs470015242 | 245 | D>E | No | EVA |
No associated diseases with Q3ZBN4
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| nuclear membrane | Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space. |
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| ubiquitin binding | Binding to ubiquitin, a protein that when covalently bound to other cellular proteins marks them for proteolytic degradation. |
2 GO annotations of biological process
| Name | Definition |
|---|---|
| negative regulation of cytokine production involved in inflammatory response | Any process that stops, prevents or reduces the frequency, rate or extent of cytokine production involved in inflammatory response. |
| negative regulation of macrophage cytokine production | Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MELERIVSAA | LLAFVQTHLP | EADLSGLDDV | IFSYVLGVLG | DLGPSGPSEE | NFDMEAFTEM |
| 70 | 80 | 90 | 100 | 110 | 120 |
| MEAYVPGFAH | IPRGTIGDMI | QKLSGQLSGA | RNKENVQPQS | SEVQGQVSIS | PEPLQRPEKL |
| 130 | 140 | 150 | 160 | 170 | 180 |
| KEETMSSAGD | TQDEAAGPEE | ELLPGVDVLL | EVFPTCSVEQ | AQWVLAKARG | DLEEAVQMLV |
| 190 | 200 | 210 | 220 | 230 | 240 |
| EGKQGPPAWD | GPNQDLPRRL | RGPQKDELKS | FILQKYMMVD | SAEDQKIHRP | MAPKEAPKKL |
| 250 | 260 | 270 | 280 | ||
| IRYIDNQIVS | TKGERFKDVR | NPEAEEMKAT | YINLKPARKY | RFH |